- H99 -

Diversity and Inclusion in Cancer Health Equity Latest News Updates A Phase 3 Study of elacestrant versus standard endocrine therapy in nodepositive ER HER2 early breast cancer with high risk of recurrence ELEGANT Despite advances in the adjuvant treatment of earlystage estrogen receptorpositive ER human epidermal growth factor receptor 2negative HER2 breast cancer there continues to be a risk of recurrence. The ELEGANT study is a Global Multicenter Randomized Openlabel Phase 3 Study with the primary goal to evaluate the efficacy and safety of elacestrant versus standard endocrine Continue Reading Applications Are Open for the ASCO Quality Training Program QTP ASCOs Quality Training Program QTP Winter 2025 Session will be on the following dates hosted by Memorial Healthcare System in Pembroke Pines Florida Learning Session 0 Orientation Thursday December 5 2024 Virtual Learning Session 1 Thursday January 9 Friday January 10 2025 inperson Learning Session 2 Thursday March 6 Friday March 7 2025 Continue Reading Meritbased Incentive Payment System MIPS Automatic Extreme and Uncontrollable Circumstances EUC Policy Applied to MIPS Eligible Clinicians Following Hurricanes Helene and Francine The U. S. Department of Health and Human Services HHS Secretary Becerra recently released a letter to healthcare leaders and stakeholders on the impacts of Hurricane Helene which can be found on the HHS website.